HIVresistanceWeb Board - Robert William Shafer, MD

Advisory Board

Robert Shafer

Robert William Shafer, MD

rshafer@cmgm.stanford.edu

Center for AIDS Research
Division of Infectious Diseases
Stanford University Medical Center
Stanford, CA

Positions
Assistant Professor
Center for AIDS Research
Division of Infectious Diseases
Stanford University Medical Center

Date of Birth
January 17, 1958

Education
Columbia University (BA, 1979)

New York University School of Medicine (MD, 1983)

Areas of Specialty
Infectious disease, antiretroviral drug resistance

Recent Publications

Shafer RW, Warford A, Winters MA, Gonzalez MJ. Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected patients. J Virol Methods. 2000;86:143-53.

Demeter LM, Shafer RW, Meehan PM, Holden-Wiltse J, Fischl MA, Freimuth WW, Para MF, Reichman RC. Phenotypic susceptibilities and associated reverse transcriptase mutations in human immunodefeciency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother. 2000;44:794-797.

Zolopa A, Shafer RW, Montoya JG, Warford A, Merigan TC, Efron BA. HIV genotypic predictors of response to saquinavir/ritonavir combination therapy in patients who have failed prior protease inhibitors: A clinical cohort study. Ann Intern Med. 1999;131:813-821.

Palmer S, Shafer RW, Merigan TC. Highly drug-resistant HIV-1 isolates are cross-resistant to many of the current anti-HIV compounds in clinical development AIDS. 1999;13:661-667.

Shafer RW, Hsu P, Patick A, Craig C, Brendel V. Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors. J Virol. 1999;73:6197-6202.

(click titles to read abstracts)

back to the top of this page